The OSBPL9 antibody is a polyclonal rabbit IgG antibody designed to target the oxysterol-binding protein-like 9 (OSBPL9), a key regulator of cholesterol transport and Golgi apparatus function. Its primary role is to detect OSBPL9 protein expressions in human and mouse samples via Western blot (WB), immunohistochemistry (IHC), and enzyme-linked immunosorbent assay (ELISA) .
The antibody has been validated for:
Western Blot: Detects OSBPL9 in human brain, testis, and mouse lung tissues at dilutions of 1:500–1:1000 .
Immunohistochemistry: Stains human testis and colon cancer tissues, requiring antigen retrieval with TE buffer (pH 9.0) or citrate buffer (pH 6.0) .
ELISA: Used for quantitative detection of OSBPL9 in lysates or sera.
OSBPL9 functions as a cholesterol transfer protein, mediating sterol transport between the endoplasmic reticulum (ER) and trans-Golgi/TGN, ensuring Golgi integrity and protein trafficking . Its depletion via RNAi disrupts Golgi structure and impairs vesicular transport, while overexpression of a dominant-negative variant (ORP9S) halts protein secretion entirely .
Lysosomal Repair Pathways: The antibody was used to demonstrate that OSBPL9 interacts with ORP10 to transfer phosphatidylinositol 4-phosphate (PI-4P) at ER-TGN contact sites, facilitating lysosomal membrane repair .
Golgi Fragmentation: Studies employing this antibody revealed that OSBPL9 knockdown leads to Golgi fragmentation and endosomal cholesterol accumulation, underscoring its role in lipid homeostasis .
Wyles and Ridgway (2004): Role of ORP9 in ER-Golgi sterol transport.
Proteintech (2023): OSBPL9 antibody validation data and publications.
National Library of Medicine (2025): OSBPL9 gene entry (public domain).